Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.
about
Understanding Critical Quality Attributes for Nanocrystals from Preparation to DeliveryPharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulationsHaste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating FormulationsPreparation and in vivo evaluation of a dutasteride-loaded solid-supersaturatable self-microemulsifying drug delivery system.Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride.Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallizationSolid-state characterization of Felodipine-Soluplus amorphous solid dispersions.Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs.Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.Analytical technologies for real-time drug dissolution and precipitation testing on a small scale.The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.Mesoporous silica-based dosage forms improve bioavailability of poorly soluble drugs in pigs: case example fenofibrate.Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.Oral bioavailability enhancement through supersaturation: an update and meta-analysis.Encapsulation and Delivery of Crystalline Hydrophobic Nutraceuticals using Nanoemulsions: Factors Affecting Polymethoxyflavone Solubility.The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility.Combined use of crystalline sodium salt and polymeric precipitation inhibitors to improve pharmacokinetic profile of ibuprofen through supersaturation.Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments.Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs.Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.Extended release of flurbiprofen from tromethamine-buffered HPMC hydrophilic matrix tablets.Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight.Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.A pre-formulation study of a polymeric solid dispersion of paclitaxel prepared using a quasi-emulsion solvent diffusion method to improve the oral bioavailability in rats.Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.Inhibition of solution crystal growth of ritonavir by cellulose polymers – factors influencing polymer effectivenessDual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion
P2860
Q26772050-7ECD43BA-0812-41FC-A383-A861CD376421Q28084784-CE355EF2-7270-42C0-BD5C-9FC033B5A94CQ30378760-17792A95-4923-4A1F-A48D-D0FC1B8FD51EQ35723500-2BD55E95-09E8-46DF-905C-0D41F8CF6A16Q35794494-4F547F2F-197E-4AEC-B241-62DC46766154Q36009014-D2C0E8BE-D8A4-4B00-8CA9-CB8203EFF2D5Q37066636-35DC436B-1527-4ABC-A83D-DE3AA1A0CC1BQ38026509-15CEE709-9E21-4679-BF8B-77CA184DD124Q38119168-B811322E-8027-40BF-81CF-1B210287F601Q38199539-EFB2A257-CDCD-411C-824B-146625F1FBFAQ38212289-1A60C6E8-05D7-493C-A212-4C7E00EA42E0Q38644728-6C1F46B0-0F91-49E7-ADC5-9FC1F9C9F70CQ38669102-EC31CF66-17B0-4486-AE02-8D63955D7838Q38729314-7AAA2EBB-E27C-4613-BAE9-93DF54AAFDBAQ38917369-0CA03B20-2B58-4D06-9042-3BDF5B525BB6Q40261316-A6FE5DE6-CAD9-4123-9C8B-288E72E586CDQ41335984-02D05019-7D96-4D1B-BA71-06FB53B53CF1Q41902404-074950EC-5536-485E-8FB8-0C24F6A4B231Q44032375-1FD4324A-6916-4FDC-B154-00D3E1922E32Q45339496-A872AFF0-E5E2-4E31-8A58-1E2442D51DC3Q45831325-53A5E5F9-211B-43CA-B1E6-570EEA78F8D3Q46403625-6475D612-951C-400F-9D96-1BF77ECEAC94Q47364783-1F31DA21-9B0D-45F0-B9E6-8477DD3C924EQ47729955-F2D1FFBA-A655-4786-8C9B-5C439057CA7EQ47838404-7BEB1D7A-47FC-43A4-930C-150D14E455BAQ48627689-25F4C80B-2202-4F4F-85C0-C8FEB6B46D71Q50955791-DD0D8683-EB07-45A8-B276-9FCCDEC35948Q51026873-59909B69-CBBC-4A7D-B501-BA4AB8776443Q51706707-07519A22-D39D-4BD1-9963-3D4FE66E6457Q57376538-813E14BE-20A2-49D2-8519-7557EB589FB9Q57785804-5958CCE4-2AAA-433C-A18D-82EFA3C1FF75
P2860
Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using polymeric precipitation ...... mechanistic basis for utility.
@en
Using polymeric precipitation ...... mechanistic basis for utility.
@nl
type
label
Using polymeric precipitation ...... mechanistic basis for utility.
@en
Using polymeric precipitation ...... mechanistic basis for utility.
@nl
prefLabel
Using polymeric precipitation ...... mechanistic basis for utility.
@en
Using polymeric precipitation ...... mechanistic basis for utility.
@nl
P2860
P1476
Using polymeric precipitation ...... mechanistic basis for utility
@en
P2093
Dallas B Warren
Hassan Benameur
P2860
P304
P356
10.3109/1061186X.2010.525652
P577
2010-10-26T00:00:00Z